Overweight, obesity and incident atrial fibrillation: Real‐world evidence from 400 000 patients in Germany

Abstract Aims Obesity is a well‐established risk factor for atrial fibrillation (AF). However, the extent to which this association is driven by obesity‐related comorbidities such as hypertension, diabetes and heart failure versus a potential direct effect of obesity itself remains unclear. Differentiating between these pathways is important for developing effective and targeted prevention strategies. To investigate the association between body mass index (BMI) and incident AF using both multivariable Cox regression and causal mediation analysis (CMA), quantifying the extent to which this risk is mediated by obesity‐related comorbidities. Materials and Methods This retrospective cohort study used the Disease Analyzer database (IQVIA) to identify patients aged ≥40 years with documented BMI in German general practices between 2005 and 2023. Patients were categorised as normal weight (18.5–24.9 kg/m 2 ), overweight (25.0–29.9 kg/m 2 ) or obese (≥30 kg/m 2 ). The primary outcome was a new diagnosis of AF within 10 years. Multivariable Cox regression models were used and adjusted for age, sex and cardiometabolic comorbidities. CMA was used to estimate the proportion of AF risk mediated through diabetes, hypertension, dyslipidaemia, coronary artery disease and heart failure. Results Of the 392 146 patients included in the study, AF incidence was 7.2% in normal weight, 10.1% in overweight and 13.2% in obese individuals over 10 years. Obesity was associated with a significant increase in AF risk (HR 1.43; 95% CI 1.38–1.48), with a higher risk observed in men. CMA showed that 27% of the obesity‐related AF risk (106% excess total risk) was mediated through comorbidities, while 79% represented a direct effect. In women, the proportion of mediated effects was higher (up to 30.1%), suggesting sex‐specific differences in disease pathways. Conclusions Obesity significantly increases the risk of AF through both comorbidity‐related and potentially independent pathways. While nearly one‐third of the excess risk may be preventable through the management of cardiometabolic conditions, a notable proportion of the association remains unexplained by these mediators. These findings highlight the need for comprehensive strategies that address both obesity itself and its associated diseases to reduce the burden of AF.